Table 3 Mean annual ingredient cost of chronic comorbidity in the study population with and without T2DM
Sex | Age (yrs) | T2DM group | Non T2DM group | Cost ratio * |
|---|---|---|---|---|
Male | ||||
65-69 | 1183. 43 [1182.12, 1184.75] | 683. 85 [683.41, 684.28] | 1.73 | |
70-74 | 1184. 35 [1183.22, 1185.47] | 744. 02 [743.67, 744.37] | 1.59 | |
≥75 | 1245. 51 [1244.65, 1246.36] | 871. 33 [871.02, 871.65] | 1.45 | |
Female | ||||
65-69 | 1223. 89 [1222.43, 1225.31] | 667.52 [667.16, 667.88] | 1.83 | |
70-74 | 1293. 06 [1291.74, 1294.38] | 764.89 [764.57, 765.22] | 1.69 | |
≥75 | 1279. 10 [1278.05, 1280.14] | 882.95 [882.71, 883.18] | 1.45 | |
No. of comorbid conditions | ||||
0 | 0 | 0 | 1 | |
1 | 193. 45 [192.82, 194.08] | 225.02 [224.86, 225.17] | 0.86 | |
2 | 386. 59 [385.99, 387.20] | 414.52 [414.34, 414.69] | 0.93 | |
3 | 628. 65 [628.10, 629.21] | 628.35 [628.15, 628.54] | 1 | |
4 | 897. 08 [896.42, 897.74] | 874.86 [874.60, 875.11] | 1.03 | |
5 | 1186. 88 [1186.14, 1187.62] | 1153.70 [1153.38, 1154.02] | 1.03 | |
6 | 1485. 14 [1484.16, 1486.13] | 1454.08 [1153.38, 1154.02] | 1.02 | |
7 | 1807.74 [1806.40, 1809.08] | 1764.68 [1764.05, 1765.31] | 1.02 | |
8 | 2130. 86 [2129.05, 2132.67] | 2078.91 [2078.03, 2079.79] | 1.03 | |
9 | 2461. 44 [2458.71, 2464.17] | 2436.44 [2435.00, 2437.87] | 1.01 | |
≥10 | 3151. 03 [3146.39, 3155.67] | 3023.80 [3022.13, 3025.46] | 1.04 | |